Ian Thompson
Mentor @Nhs Innovation Accelerator
Signup · Get unlimited contacts
WORK HISTORY
Mentor @Nhs Innovation Accelerator
London, GB
The NIA alongside the AHSNs supports the scaling of high-impact, evidence-based innovations across the NHS. We were within the first cohort of companies at the start of the NIA programme. I have worked with the NIA directors initially on the brand growth within the NHS and later in the programme within a mentorship support network focusing on commercial recruiting strategies, commercialisation plans, and how to spend investment from funding rounds.
EDUCATION
Embry-Riddle Aeronautical University
Bachelor of Science, Aviation Business Management
Cornelius Vermuyden
GCSE, Various
City College Norwich
Diploma, Business
SKILLS
ABOUT IAN THOMPSON
Commercial Leader in Digital Therapeutics | NHS Adoption Strategist | Healthcare InnovatorIan is a digital health commercialisation expert with over a decade of experience driving adoption and market success in the NHS and international healthcare systems. For the past seven years, he has led the commercial strategy at my mhealth, where he has been instrumental in positioning the company as a market leader in digital therapeutics. His expertise lies in navigating complex healthcare commissioning structures — from ICSs and CCGs to Trusts and STPs — and driving uptake through innovative market access strategies.Ian joined my mhealth in 2015 with a bold mandate: to achieve NHS commissioning of digital self-management apps within routine patient care. Under his leadership, the company launched six nationally recognised digital health products, delivering measurable impact and commercial return. His work spans the entire NHS landscape, from Primary and Secondary Care to central NHS innovation frameworks, including the Innovation & Technology Tariff.He is also part of the NHS Innovation Accelerator mentorship network, supporting early-stage healthtech companies with commercial strategy and recruitment planning.Prior to his work in digital health, Ian graduated Magna Cum Laude in Aviation Business Management from Embry-Riddle Aeronautical University (Florida), where he attended on a soccer scholarship. He began his career at GlaxoSmithKline, quickly advancing in their global commercial pharmaceutical division. In 2014, he led GSK’s launch strategy for three new respiratory drugs, achieving portfolio-first formulary inclusion and setting a benchmark for launch excellence.Ian brings a rare blend of experience across pharmaceuticals, digital health, commercial sales, and NHS system transformation, making him a sought-after voice in the evolving digital therapeutics landscape.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.